Results 261 to 270 of about 3,927,360 (403)

Synthetic exfoliative toxin A and B DNA probes for detection of toxigenic Staphylococcus aureus strains

, 1989
Samer Rifai, V Barbancon, Gilles Prévost, Y. Piémont   +3 more
openalex   +1 more source

Generation of DNA probes for peptides with highly degenerate codons using mixed primer PCR [PDF]

, 1988
Samia I. Girgis, Maria Alevizaki, Paul Denny, G. Ferrier, S. Legon   +4 more
openalex   +1 more source

Quantitative and spatially resolved detection of multiplexed microRNA from plant tissue via hybridization to hydrogel-bound DNA probes in nanoliter well arrays. [PDF]

Microsyst Nanoeng
Fang J, Doyle PS.
europepmc   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Rapid detection of DNA-binding factors using protein-blotting and digoxygenine-dUTP marked probes

, 1988
Steven Dooley, Janna Radtke, Nikolaus Blin, Gerhard Unteregger   +3 more
openalex   +2 more sources

Immunological capture of nucleic acid hybrids and application to nonradioactive DNA probe assay. [PDF]

, 1987
Ayoub Rashtchian, John Eldredge, Margaret Ottaviani, M.T. Abbott, Graham A. Mock, Douglas Lovern, Jeffrey D. Klinger, Gibbe H. Parsons   +7 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

A novel and rapid method to generate single stranded DNA probes for genomic footprinting [PDF]

, 1988
Falk Weih, A. Francis Stewart, Günther Shütz   +2 more
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

Detection of Campylobacter pylori DNA by hybridisation with non-radioactive probes in comparison with a 32P-labelled probe

, 1988
B L Wetherall, P. J. McDonald, Alan M. Johnson   +2 more
openalex   +1 more source